top of page
신문

PR

NEWS ROOM

Highlights of Cell Biotech at Vitafoods 2024 in Geneva, Switzerland


We are thrilled to share the highlights of Cell Biotech's participation at Vitafoods 2024 in Geneva, Switzerland. This year's event was held from May 14th to May 16th, and it was a truly fruitful experience for us.


Meeting Clients and Building Connections

Throughout the event, we had the opportunity to meet numerous clients and industry professionals. These interactions were incredibly valuable, providing us with insights and fostering relationships that will undoubtedly contribute to our future growth.


Promoting Our FDA GRAS Status Strains

A major highlight was promoting our strains that have received FDA GRAS (Generally Recognized As Safe) status. This notification is a testament to the safety and quality of our products, and we were excited to share this with our clients.


Sharing Company Information and Introducing New Products

We took the chance to share detailed information about our company, our mission, and our innovative approach to biotechnology. Additionally, we introduced some of our latest products, which were very well received by the visitors.


Showcasing New Products at the New Product Zone

One of the key attractions at our booth was the showcase of our new products, Slim Pet and Fresh Morning, at the New Product Zone. These products are designed to meet the evolving needs of our consumers and highlight our commitment to innovation.


Gratitude to Our Visitors

We would like to extend our heartfelt thanks to everyone who visited our booth. Your interest and support mean the world to us, and we look forward to continuing our conversations and collaborations.


See You in 2025 in Spain!

As we wrap up our time at Vitafoods 2024, we are already looking forward to next year's event. Mark your calendars for Vitafoods 2025 in Spain, and we can't wait to see you there!

Thank you once again for making Vitafoods 2024 a success.


See you next year!

Stay tuned for more updates and follow us on our journey towards innovation and excellence in microbiotechnology.


116 views
bottom of page